Global Vascular Graft Market Size By Product Type, By Application, By End User, By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Vascular Graft Market size was valued at USD 4.58 Billion in 2023 and is projected to reach USD 6.08 Billion by 2030,growing at a CAGR of 8.38%during the forecast period 2024-2030.
Global Vascular Graft Market Drivers
The market drivers for the Vascular Graft Market can be influenced by various factors. These may include
Cardiovascular Disease (CVD) Prevalence One major factor propelling the market for vascular grafts is the rising prevalence of cardiovascular illnesses such aneurysms, peripheral artery disease, and coronary artery disease. The need for vascular grafts increases in tandem with the frequency of surgical operations necessary to treat these disorders.
Aging Population As a result of a movement in global demography toward an aging population, cardiovascular disorders are becoming more common. Conditions like atherosclerosis and aneurysms, which frequently require vascular graft surgeries, are more common in older people.
Technological Developments Vascular graft materials, designs, and manufacturing methods are always evolving, which drives market expansion. Vascular graft adoption rates are boosted by innovations like drug-eluting grafts, bioengineered grafts, and minimally invasive surgical methods, which improve the vascular grafts’ longevity and efficacy.
Growing Number of Surgical Procedures The need for vascular grafts is fueled by the growing number of vascular operations carried out globally, such as peripheral artery bypass, coronary artery bypass grafting (CABG), and vascular access procedures for hemodialysis patients.
Preference for Minimally Invasive Procedures Minimally invasive surgical procedures are becoming more and more popular in vascular operations. Vascular grafts appropriate for minimally invasive operations are in high demand since they provide advantages such shortened recovery times, decreased risk of complications, and better patient outcomes.
Developing Healthcare Infrastructure Better access to surgical procedures and cardiovascular treatment is a result of improvements in healthcare infrastructure, especially in developing nations. In areas where the infrastructure for healthcare is developing, the demand for vascular grafts is driven by this greater accessibility.
Policies for reimbursement and the regulatory environment Adopting improved vascular grafts is encouraged by favorable regulatory frameworks and reimbursement policies for vascular procedures and related devices. Efficient regulatory frameworks and sufficient compensation promote market expansion by incentivizing research and development expenditures.
Global Vascular Graft Market Restraints
Several factors can act as restraints or challenges for the Vascular Graft Market. These may include
Expensive Procedures Vascular graft operations can be costly, whether they are performed for bypass operations or other vascular interventions. The graft itself, surgical supplies, hospital stay, and post-operative care are all included in this price. The high expense can prevent certain patients from having access to these operations, especially in areas with little insurance or healthcare resources.
Risk of Complications Even with improvements in surgical methods and vascular graft technology, problems can still arise. Graft rejection, infection, thrombosis, and failure are possible outcomes. Patients and medical professionals may be discouraged from undergoing vascular graft procedures due to worries about possible complications, particularly when there are other options for therapy.
Scarce Supply of Qualified Surgeons Vascular graft procedures call for certain education and experience. There might not be as many vascular surgeons available in some areas who are qualified and experienced to carry out these treatments. Growth in the market may be impeded by this restriction on access to vascular graft procedures.
Durability and Extended Life Concerns A number of variables, including material composition, design, and patient-specific traits, might affect how long-lasting and effective vascular grafts are. Concerns over the durability of grafts and the necessity of prospective follow-up procedures could impact treatment choices and restrict market expansion.
Regulatory Obstacles Health authorities in many nations have the authority to oversee the regulation of vascular grafts as medical devices. It can take a lot of time and money for manufacturers to comply with regulatory standards, such as getting approvals or certifications for new items or revisions. Market introduction of novel graft technologies could be impeded by regulatory obstacles.
Competition from Alternative Therapies Vascular grafts may face competition from alternative therapies for vascular disorders, including medication, lifestyle changes, or endovascular operations. Less invasive or less expensive methods may be chosen by patients and healthcare professionals, especially in situations when the dangers of vascular grafts outweigh the benefits or where the advantages are unclear.
Legal and Ethical Issues The use of vascular grafts may give rise to legal and ethical issues, especially when it comes to using synthetic materials that may have long-term health effects or obtaining graft materials from human donors. Discussions on law and ethics may affect how the general public views and accepts vascular grafts.
Global Vascular Graft Market Segmentation Analysis
The Global Vascular Graft Market is Segmented on the basis of Product Type, Application, End User, And Geography.
Vascular Graft Market, By Product Type
Endovascular Aneurysm Repair (EVAR) Grafts Abdominal aortic aneurysms are treated with endovascular aneurysm repair (EVAR) grafts, which are performed during minimally invasive operations.
Peripheral Vascular Grafts A therapy for peripheral arterial disease used in bypass procedures.
Hemodialysis Access Grafts Used to provide renal failing patients with access for hemodialysis treatments.
Coronary Artery Bypass Grafts (CABG) Used to bypass obstructive coronary arteries during heart surgery.
Vascular Graft Market, By Application
Aneurysm repair focuses on treating peripheral or aortic aneurysms.
vascular occlusion repair Resolving obstructions or occlusions in blood arteries is known as vascular occlusion repair.
Hemodialysis Access Enabling renal failing patients to receive dialysis treatments.
Coronary Artery Bypass Surgery Helping patients with coronary artery disease receive more blood to their heart muscles.
Vascular Graft Market, By End User
Hospitals and Clinics Vascular grafts are widely used in hospitals and clinics for a variety of surgical procedures.
Ambulatory Surgical Centers (ASCs) Ambulatory Surgical Centers, or ASCs, are becoming more and more common for outpatient vascular procedures.
Specialty Centers Dedicated facilities that specialize in vascular surgery, particularly in intricate situations.
Vascular Graft Market, By Geography
North America Market conditions and demand in the United States, Canada, and Mexico.
Europe Analysis of the Vascular Graft Market in European countries.
Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
Middle East and Africa Examining market dynamics in the Middle East and African regions.
Latin America Covering market trends and developments in countries across Latin America.
 Key Players
The major players in the Vascular Graft Market are
Medtronic plc
C.R. Bard, Inc. (a subsidiary of Becton, Dickinson and Company)
Terumo Corporation
Cook Medical Inc. (a subsidiary of Cook Group Incorporated)
W. L. Gore & Associates, Inc.
LeMaitre Vascular, Inc.
Endologix, Inc.
B. Braun Melsungen AG
Cardinal Health, Inc.
MAQUET Holding B.V. & Co. KG (a subsidiary of Getinge AB)
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2020-2030
BASE YEAR
2023
FORECAST PERIOD
2024-2030
HISTORICAL PERIOD
2020-2022
UNIT
Value (USD Billion)
KEY COMPANIES PROFILED
Medtronic plc, C.R. Bard, Inc. (a subsidiary of Becton, Dickinson and Company), Terumo Corporation, Cook Medical Inc. (a subsidiary of Cook Group Incorporated), W. L. Gore & Associates, Inc., LeMaitre Vascular, Inc., Endologix, Inc., B. Braun Melsungen AG.
SEGMENTS COVERED
By Product Type, By Application, By End User, By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We dig into the market using both qualitative and quantitative methods, segmenting it by things like the economy, but also the stuff that's harder to measure. We'll give you the market value (in USD Billion) for every little piece of the market. We'll also point out which areas and segments are likely to grow the quickest and be the biggest overall. Think of it as a guided tour of the market, region by region, showing you what people are buying and what's influencing their choices. Plus, we'll lay out the competitive landscape, ranking the major players and highlighting new products, partnerships, expansions, and acquisitions from the last five years. You'll get detailed profiles of the big companies, including their story, insights, product comparisons, and SWOT analysis. We'll cover both the current and future outlook, looking at recent happenings, growth opportunities, drivers, and the challenges in both up-and-coming and established regions. We'll even give you an in-depth look at the market through Porter's five forces analysis, and provide a Value Chain perspective. Finally, we'll map out the market dynamics and future growth possibilities. Oh, and we'll throw in 6 months of analyst support after you buy.
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
